| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.15▲ | 1.14▲ | 1.14▲ | 1.15▲ | 1.14▲ |
| MA10 | 1.14▲ | 1.13▲ | 1.13▲ | 1.15▲ | 0.97▲ |
| MA20 | 1.13▲ | 1.12▲ | 1.14▲ | 1.15▲ | 0.86▲ |
| MA50 | 1.14▲ | 1.14▲ | 1.14▲ | 0.90▲ | 1.03▲ |
| MA100 | 1.13▲ | 1.14▲ | 1.14▲ | 0.82▲ | 3.10▼ |
| MA200 | 1.14▲ | 1.16▼ | 0.97▲ | 0.92▲ | 8.89▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.005▲ | 0.004▲ | 0.002▲ | -0.015▼ | 0.087▲ |
| RSI | 59.766▲ | 59.345▲ | 55.236▲ | 57.835▲ | 54.132▲ |
| STOCH | 95.139▲ | 92.109▲ | 86.946▲ | 51.986 | 51.330 |
| WILL %R | -6.667▲ | -6.667▲ | -17.647▲ | -54.817 | -50.871 |
| CCI | 102.115▲ | 135.373▲ | 111.111▲ | 17.881 | 64.146 |
|
Monday, December 22, 2025 04:00 PM
Pasithea Therapeutics Corp., a clinical-stage biotechnology company, focuses on the discovery, research, and development of treatments for central nervous system (CNS) disorders, RASopathies, and ...
|
|
Wednesday, November 26, 2025 02:57 AM
What To Know: The Hoffman ALS Clinical Trial Award will fund a clinical study evaluating the efficacy, safety and tolerability of PAS-004 in patients with amyotrophic lateral sclerosis, expanding the ...
|
|
Wednesday, June 11, 2025 04:14 AM
Pasithea Therapeutics Corp. has announced the appointment of Dr. James Lee to its scientific advisory board to assist in the development of PAS-004, a macrocyclic MEK inhibitor aimed at treating ETS2 ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 30/12/25 | 1.14 | 1.16 | 1.135 | 1.155 | 45,707 |
| 29/12/25 | 1.14 | 1.14 | 1.085 | 1.14 | 245,100 |
| 26/12/25 | 1.16 | 1.17 | 1.10 | 1.12 | 147,800 |
| 24/12/25 | 1.16 | 1.17 | 1.12 | 1.17 | 135,482 |
| 23/12/25 | 1.15 | 1.183 | 1.15 | 1.16 | 164,042 |
| 22/12/25 | 1.13 | 1.205 | 1.13 | 1.18 | 465,000 |
| 19/12/25 | 1.09 | 1.16 | 1.019 | 1.16 | 655,400 |
| 18/12/25 | 1.13 | 1.1799 | 1.075 | 1.10 | 521,780 |
| 17/12/25 | 1.13 | 1.22 | 1.13 | 1.14 | 424,700 |
| 16/12/25 | 1.16 | 1.18 | 1.10 | 1.14 | 766,045 |
|
|
||||
|
|
||||
|
|